{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:37:21Z","timestamp":1792615041284,"version":"4.5.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatocellular carcinoma (HCC) and colorectal cancer (CRC) are major causes of cancer-related mortality, yet responses to immune checkpoint inhibitors (ICIs) remain heterogeneous. Although programmed death-ligand 1 (PD-L1) is a key component of immune checkpoint biology, antitumor immunity is shaped by multiple tumor-intrinsic and microenvironmental factors, and the contribution of the long non-coding RNA H19 to these processes remains incompletely defined. This narrative review synthesizes experimental and clinical evidence linking H19 to immune regulation in HCC and CRC, with particular emphasis on its potential intersection with PD-L1-mediated immune checkpoint signaling. Evidence was classified as experimentally demonstrated, indirectly supported, contextual, or hypothetical according to the strength, mechanistic resolution, and disease specificity of the available data. Current evidence indicates that H19 perturbation can influence PD-L1-associated phenotypes in selected experimental HCC models; however, a complete, mechanistically resolved H19-dependent PD-L1 regulatory axis, including validated intermediate mechanisms and causal rescue, has not been established in HCC or CRC. Proposed ceRNA and signaling mechanisms remain incompletely validated, while several mechanistic links are supported primarily by indirect or cross-cancer evidence. Beyond direct checkpoint regulation, H19-associated extracellular vesicles and H19-dependent signaling have been implicated in macrophage remodeling, intercellular communication, and T-cell dysfunction, although direct convergence of these processes on H19-mediated PD-L1 regulation remains unproven. Circulating H19 has also shown preliminary associations with tumor presence or burden, but its clinical utility as a diagnostic, prognostic, or predictive biomarker remains insufficiently validated, particularly for ICI response. Overall, H19 represents a biologically plausible interface between non-coding RNA regulation, tumor-intrinsic signaling, and the tumor immune microenvironment rather than an established central regulator of PD-L1. Disease-specific mechanistic studies incorporating H19 perturbation, PD-L1 measurement, pathway-specific rescue, and immune-functional assays are required to determine whether H19 can serve as a clinically actionable component of immune checkpoint regulation.<\/jats:p>","DOI":"10.1007\/s10238-026-02319-9","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T11:33:21Z","timestamp":1788694401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["H19 and the PD-1\/PD-L1 Axis in hepatocellular carcinoma and colorectal cancer: emerging evidence, mechanistic links, and therapeutic perspectives"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9446-1769","authenticated-orcid":false,"given":"Mohammad Taha","family":"Nami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"EmamiPari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nooshin","family":"Farrokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliya","family":"Fattahyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Yekkalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,6]]},"reference":[{"key":"2319_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/or.2026.1763632","volume":"20","author":"W-J Wang","year":"2026","unstructured":"Wang W-J, Yuan H-X, Xu J-Z, Wang X-D, Na G-W, He K-J, et al. New understanding of the molecular pathogenesis and therapeutic progress of hepatocellular carcinoma. Oncol Rev. 2026;20:1763632.","journal-title":"Oncol Rev"},{"issue":"2","key":"2319_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000543921","volume":"106","author":"T Matsuda","year":"2025","unstructured":"Matsuda T, Fujimoto A, Igarashi Y. Colorectal cancer: epidemiology, risk factors, and public health strategies. Digestion. 2025;106(2):91\u20139.","journal-title":"Digestion"},{"issue":"3","key":"2319_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2022;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"2319_CR4","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/s41590-024-02015-4","volume":"25","author":"S Goswami","year":"2024","unstructured":"Goswami S, Pauken KE, Wang L, Sharma P. Next-generation combination approaches for immune checkpoint therapy. Nat Immunol. 2024;25(12):2186\u201399.","journal-title":"Nat Immunol"},{"issue":"9","key":"2319_CR5","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41416-025-03133-y","volume":"133","author":"N Koelsch","year":"2025","unstructured":"Koelsch N, Manjili MH. Moving beyond cytotoxicity in cancer immunotherapy: embracing tumor microenvironment remodeling for durable control: Cellular and Molecular Biology. Br J Cancer. 2025;133(9):1233\u201340.","journal-title":"Br J Cancer"},{"issue":"6382","key":"2319_CR6","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359(6382):1350\u20135.","journal-title":"Science"},{"issue":"Supplement1","key":"2319_CR7","first-page":"vkaf283","volume":"214","author":"MH Manjili","year":"2025","unstructured":"Manjili MH, Koelsch NJ. A shift from cytotoxicity to tissue remodeling immunotherapy for achieving cancer cure 3094. J Immunol. 2025;214(Supplement1):vkaf283.","journal-title":"J Immunol"},{"issue":"1","key":"2319_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","volume":"18","author":"X Jiang","year":"2019","unstructured":"Jiang X, Wang J, Deng X, Xiong F, Ge J, Xiang B, et al. Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape. Mol Cancer. 2019;18(1):10.","journal-title":"Mol Cancer"},{"key":"2319_CR9","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101819-024752","author":"HN Bell","year":"2024","unstructured":"Bell HN, Zou W. Beyond the barrier: unraveling the mechanisms of immunotherapy resistance. Annu Rev Immunol. 2024. https:\/\/doi.org\/10.1146\/annurev-immunol-101819-024752.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2319_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41420-021-00678-8","volume":"7","author":"S Zhao","year":"2021","unstructured":"Zhao S, Zhang X, Chen S, Zhang S. Long noncoding RNAs: fine-tuners hidden in the cancer signaling network. Cell Death Discovery. 2021;7(1):283.","journal-title":"Cell Death Discovery"},{"issue":"1","key":"2319_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41420-024-01832-8","volume":"10","author":"Y Xia","year":"2024","unstructured":"Xia Y, Pei T, Zhao J, Wang Z, Shen Y, Yang Y, et al. Long noncoding RNA H19: functions and mechanisms in regulating programmed cell death in cancer. Cell Death Discov. 2024;10(1):76.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2319_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12964-026-02738-x","volume":"24","author":"M Loria","year":"2026","unstructured":"Loria M, Anello D, Cordaro A, Zichittella C, Fontana S, Alessandro R, et al. Long non-coding RNA H19 transported by colorectal cancer small extracellular vesicles promotes alternative splicing in healthy hepatocytes: new insights on liver pre-metastatic niche formation. Cell Commun Signal. 2026;24(1):194.","journal-title":"Cell Commun Signal"},{"key":"2319_CR13","doi-asserted-by":"crossref","unstructured":"Jiang Y, Xiong K. Impact of the inflammatory microenvironment on immune infiltration in colorectal and liver cancers: insights for new immunotherapeutic strategies. Frontiers; 2025. p. 1691488.","DOI":"10.3389\/fonc.2025.1691488"},{"key":"2319_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1563184","volume":"13","author":"Q-L Liu","year":"2025","unstructured":"Liu Q-L, Zhou H, Wang Z, Chen Y. Exploring the role of gut microbiota in colorectal liver metastasis through the gut-liver axis. Front Cell Dev Biol. 2025;13:1563184.","journal-title":"Front Cell Dev Biol"},{"issue":"45","key":"2319_CR15","doi-asserted-by":"publisher","first-page":"6906","DOI":"10.1038\/s41388-020-01475-w","volume":"39","author":"Z Sun","year":"2020","unstructured":"Sun Z, Xue S, Zhang M, Xu H, Hu X, Chen S, et al. Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma. Oncogene. 2020;39(45):6906\u201319.","journal-title":"Oncogene"},{"issue":"1","key":"2319_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3892\/or.2020.7608","volume":"44","author":"Y Xu","year":"2020","unstructured":"Xu Y, Liu Y, Li Z, Li H, Li X, Yan L, et al. Long non\u2011coding RNA H19 is involved in sorafenib resistance in hepatocellular carcinoma by upregulating miR\u2011675. Oncol Rep. 2020;44(1):165\u201373.","journal-title":"Oncol Rep"},{"issue":"5","key":"2319_CR17","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1007\/s10528-023-10627-y","volume":"62","author":"M Zhu","year":"2024","unstructured":"Zhu M, Yu R, Liu Y, Geng X, Liu Q, Liu S, et al. LncRNA H19 Participates in Leukemia Inhibitory Factor Mediated Stemness Promotion in Colorectal Cancer Cells. Biochem Genet. 2024;62(5):3695\u2013708.","journal-title":"Biochem Genet"},{"issue":"5","key":"2319_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3892\/etm.2021.9938","volume":"21","author":"X Gao","year":"2021","unstructured":"Gao X, Jiang Y, Li Y. Inhibitory effect of miR-140-5p on doxorubicin resistance of hepatocellular carcinoma. Exp Ther Med. 2021;21(5):507.","journal-title":"Exp Ther Med"},{"key":"2319_CR19","doi-asserted-by":"crossref","unstructured":"Xian D, Niu L, Zeng J, Wang L. LncRNA KCNQ1OT1 Secreted by Tumor Cell-Derived Exosomes Mediates Immune Escape in Colorectal Cancer by Regulating PD-L1 Ubiquitination via MiR-30a-5p\/USP22. Front Cell Dev Biology. 2021;Volume 9\u20132021.","DOI":"10.3389\/fcell.2021.653808"},{"issue":"10","key":"2319_CR20","doi-asserted-by":"publisher","first-page":"7071","DOI":"10.1002\/jcp.30378","volume":"236","author":"E Roshani Asl","year":"2021","unstructured":"Roshani Asl E, Rasmi Y, Baradaran B. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling. J Cell Physiol. 2021;236(10):7071\u201387.","journal-title":"J Cell Physiol"},{"key":"2319_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001895","author":"C Liu","year":"2021","unstructured":"Liu C, Liu R, Wang B, Lian J, Yao Y, Sun H, et al. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer. J Immunother Cancer. 2021. https:\/\/doi.org\/10.1136\/jitc-2020-001895.","journal-title":"J Immunother Cancer"},{"key":"2319_CR22","doi-asserted-by":"publisher","first-page":"6619730","DOI":"10.1155\/2021\/6619730","volume":"2021","author":"H Xu","year":"2021","unstructured":"Xu H, Ding Y, Yang X. Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K\/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells. Biomed Res Int. 2021;2021:6619730.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2319_CR23","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1002\/ctm2.255","volume":"11","author":"L Yan","year":"2021","unstructured":"Yan L, Liu G, Wu X. The umbilical cord mesenchymal stem cell-derived exosomal lncRNA H19 improves osteochondral activity through miR-29b-3p\/FoxO3 axis. Clin Transl Med. 2021;11(1):e255.","journal-title":"Clin Transl Med"},{"issue":"4","key":"2319_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41419-021-03556-4","volume":"12","author":"S Xu","year":"2021","unstructured":"Xu S, Wang X, Yang Y, Li Y, Wu S. LSD1 silencing contributes to enhanced efficacy of anti-CD47\/PD-L1 immunotherapy in cervical cancer. Cell Death Dis. 2021;12(4):282.","journal-title":"Cell Death Dis"},{"key":"2319_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119353","volume":"277","author":"MM Hamed","year":"2021","unstructured":"Hamed MM, Handoussa H, Hussein NH, Eissa RA, Abdel-Aal LK, El Tayebi HM. Oleuropin controls miR-194\/XIST\/PD-L1 loop in triple negative breast cancer: new role of nutri-epigenetics in immune-oncology. Life Sci. 2021;277:119353.","journal-title":"Life Sci"},{"key":"2319_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030519","author":"E Anastasiadou","year":"2021","unstructured":"Anastasiadou E, Messina E, Sanavia T, Mundo L, Farinella F, Lazzi S, et al. MiR-200c-3p contrasts PD-L1 induction by combinatorial therapies and slows proliferation of epithelial ovarian cancer through downregulation of \u03b2-catenin and c-Myc. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10030519.","journal-title":"Cells"},{"issue":"1","key":"2319_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23864-9","volume":"12","author":"M Wu","year":"2021","unstructured":"Wu M, Xia X, Hu J, Fowlkes NW, Li S. WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression. Nat Commun. 2021;12(1):3500.","journal-title":"Nat Commun"},{"key":"2319_CR28","doi-asserted-by":"publisher","first-page":"629893","DOI":"10.3389\/fcell.2021.629893","volume":"9","author":"L Liu","year":"2021","unstructured":"Liu L, Yu T, Jin Y, Mai W, Zhou J, Zhao C. MicroRNA-15a Carried by Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibits the Immune Evasion of Colorectal Cancer Cells by Regulating the KDM4B\/HOXC4\/PD-L1 Axis. Front Cell Dev Biol. 2021;9:629893.","journal-title":"Front Cell Dev Biol"},{"key":"2319_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12935-020-01269-w","volume":"20","author":"Z Li","year":"2020","unstructured":"Li Z, Zhang C, Du JX, Zhao J, Shi MT, Jin MW, et al. Adipocytes promote tumor progression and induce PD-L1 expression via TNF-\u03b1\/IL-6 signaling. Cancer Cell Int. 2020;20:179.","journal-title":"Cancer Cell Int"},{"issue":"11","key":"2319_CR30","first-page":"3705","volume":"10","author":"J Yan","year":"2020","unstructured":"Yan J, Zhou B, Guo L, Chen Z, Zhang B, Liu S, et al. GOLM1 upregulates expression of PD-L1 through EGFR\/STAT3 pathway in hepatocellular carcinoma. Am J Cancer Res. 2020;10(11):3705\u201320.","journal-title":"Am J Cancer Res"},{"issue":"11","key":"2319_CR31","doi-asserted-by":"publisher","first-page":"868","DOI":"10.2174\/1568009620999200730184514","volume":"20","author":"Z Li","year":"2020","unstructured":"Li Z, Gao WQ, Wang P, Wang TQ, Xu WC, Zhu XY, et al. Pentamethylquercetin Inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN-\u03b3 Signaling. Curr Cancer Drug Targets. 2020;20(11):868\u201374.","journal-title":"Curr Cancer Drug Targets"},{"issue":"3","key":"2319_CR32","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/toxres\/tfab018","volume":"10","author":"Q Xu","year":"2021","unstructured":"Xu Q, Huang S, Xu ZM, Ji K, Zhang X, Xu WP, et al. Promotion effects of DEHP on hepatocellular carcinoma models: up-regulation of PD-L1 by activating the JAK2\/STAT3 pathway. Toxicol Res (Camb). 2021;10(3):376\u201388.","journal-title":"Toxicol Res (Camb)"},{"issue":"6","key":"2319_CR33","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s41418-019-0460-0","volume":"27","author":"C Liu","year":"2020","unstructured":"Liu C, Yao Z, Wang J, Zhang W, Yang Y, Zhang Y, et al. Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65\/STAT3-CSN5-PD-L1 pathway. Cell Death Differ. 2020;27(6):1765\u201381.","journal-title":"Cell Death Differ"},{"issue":"4","key":"2319_CR34","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1053\/j.gastro.2019.11.013","volume":"158","author":"B Cen","year":"2020","unstructured":"Cen B, Lang JD, Du Y, Wei J, Xiong Y, Bradley N, et al. Prostaglandin E(2) Induces miR675-5p to Promote Colorectal Tumor Metastasis via Modulation of p53 Expression. Gastroenterology. 2020;158(4):971\u2013e8410.","journal-title":"Gastroenterology"},{"key":"2319_CR35","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.2147\/OTT.S289198","volume":"14","author":"J Wu","year":"2021","unstructured":"Wu J, Pang R, Li M, Chen B, Huang J, Zhu Y. m6A-induced LncRNA MEG3 suppresses the proliferation, migration and invasion of hepatocellular carcinoma cell through miR-544b\/BTG2 signaling. Onco Targets Ther. 2021;14:3745\u201355.","journal-title":"Onco Targets Ther"},{"key":"2319_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3298939","author":"J Xie","year":"2022","unstructured":"Xie J, Wang JJ, Li YJ, Wu J, Gu XJ, Yang XR. LncRNA GAS5 suppresses colorectal cancer progress by target miR-21\/LIFR axis. Evid Based Complement Alternat Med. 2022. https:\/\/doi.org\/10.1155\/2022\/3298939.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"2319_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10238-025-01711-1","volume":"25","author":"A Ghorbani Vanan","year":"2025","unstructured":"Ghorbani Vanan A, Nami MT, Ghorbaninezhad F, Eini P, Bagheri K, Mohammadlou M, et al. Macrophage polarization in hepatocellular carcinoma: a lncRNA-centric perspective on tumor progression and metastasis. Clin Exp Med. 2025;25(1):173.","journal-title":"Clin Exp Med"},{"key":"2319_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1467151","volume":"15","author":"J Jiao","year":"2024","unstructured":"Jiao J, Zhao Y, Li Q, Jin S, Liu Z. LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling. Front Immunol. 2024;15:1467151.","journal-title":"Front Immunol"},{"key":"2319_CR39","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.2147\/JIR.S460730","volume":"17","author":"W Li","year":"2024","unstructured":"Li W, Zhang H, You Z, Guo B. LncRNAs in immune and stromal cells remodel phenotype of cancer cell and tumor microenvironment. J Inflamm Res. 2024;17:3173\u201385.","journal-title":"J Inflamm Res"},{"key":"2319_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1395332","volume":"15","author":"MM Lu","year":"2024","unstructured":"Lu MM, Yang Y. Exosomal PD-L1 in cancer and other fields: recent advances and perspectives. Front Immunol. 2024;15:1395332.","journal-title":"Front Immunol"},{"issue":"2","key":"2319_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2024.100146","volume":"3","author":"R Liu","year":"2024","unstructured":"Liu R, Li HF, Li S. PD-1-mediated inhibition of T cell activation: mechanisms and strategies for cancer combination immunotherapy. Cell Insight. 2024;3(2):100146.","journal-title":"Cell Insight"},{"key":"2319_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1841281","volume":"17","author":"R Wang","year":"2026","unstructured":"Wang R, Guo Y. T-cell exhaustion in tumor immunology: mechanisms, heterogeneity, and therapeutic strategies. Front Immunol. 2026;17:1841281.","journal-title":"Front Immunol"},{"key":"2319_CR43","doi-asserted-by":"publisher","first-page":"1061394","DOI":"10.3389\/fimmu.2022.1061394","volume":"13","author":"M Yi","year":"2022","unstructured":"Yi M, Li T, Niu M, Wu Y, Zhao Z, Wu K. TGF-beta: A novel predictor and target for anti-PD-1\/PD-L1 therapy. Front Immunol. 2022;13:1061394.","journal-title":"Front Immunol"},{"issue":"1","key":"2319_CR44","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","volume":"21","author":"D Peng","year":"2022","unstructured":"Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-beta signal transduction for fibrosis and cancer therapy. Mol Cancer. 2022;21(1):104.","journal-title":"Mol Cancer"},{"key":"2319_CR45","doi-asserted-by":"publisher","DOI":"10.48101\/ujms.v129.10710","author":"V Milosevic","year":"2024","unstructured":"Milosevic V, Ostman A. Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential. Ups J Med Sci. 2024. https:\/\/doi.org\/10.48101\/ujms.v129.10710.","journal-title":"Ups J Med Sci"},{"issue":"1","key":"2319_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, et al. TGF-beta signaling in health, disease, and therapeutics. Signal Transduct Target Ther. 2024;9(1):61.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2319_CR47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-024-02000-1","volume":"9","author":"M Hofmann","year":"2024","unstructured":"Hofmann M, Thimme R, Schamel WW. PD-1 and LAG-3: synergistic fostering of T cell exhaustion. Signal Transduct Target Ther. 2024;9(1):291.","journal-title":"Signal Transduct Target Ther"},{"issue":"16","key":"2319_CR48","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1016\/j.cell.2024.07.016","volume":"187","author":"LP Andrews","year":"2024","unstructured":"Andrews LP, Butler SC, Cui J, Cillo AR, Cardello C, Liu C, et al. LAG-3 and PD-1 synergize on CD8(+) T cells to drive T cell exhaustion and hinder autocrine IFN-gamma-dependent anti-tumor immunity. Cell. 2024;187(16):4355\u2013e7222.","journal-title":"Cell"},{"key":"2319_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1711686","volume":"17","author":"PS Ramalingam","year":"2026","unstructured":"Ramalingam PS, Hussain MS, Khan Y, Maqbool M, Agrawal M, Dh HS, et al. Macrophage-derived long non-coding RNAs in cancer: pioneering targets for immune modulation and personalized therapy. Front Immunol. 2026;17:1711686.","journal-title":"Front Immunol"},{"key":"2319_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092411","author":"NK Shakhpazyan","year":"2023","unstructured":"Shakhpazyan NK, Mikhaleva LM, Bedzhanyan AL, Sadykhov NK, Midiber KY, Konyukova AK, et al. Long non-coding RNAs in colorectal cancer: navigating the intersections of immunity, intercellular communication, and therapeutic potential. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11092411.","journal-title":"Biomedicines"},{"issue":"14","key":"2319_CR51","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.7150\/thno.25541","volume":"8","author":"J Ren","year":"2018","unstructured":"Ren J, Ding L, Zhang D, Shi G, Xu Q, Shen S, et al. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19. Theranostics. 2018;8(14):3932\u201348.","journal-title":"Theranostics"},{"key":"2319_CR52","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.canlet.2019.11.001","volume":"469","author":"Y Ye","year":"2020","unstructured":"Ye Y, Guo J, Xiao P, Ning J, Zhang R, Liu P, et al. Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b\/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma. Cancer Lett. 2020;469:310\u201322.","journal-title":"Cancer Lett"},{"key":"2319_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010190","author":"X Li","year":"2020","unstructured":"Li X, Liu R, Wang Y, Zhu W, Zhao D, Wang X, et al. Cholangiocyte-derived exosomal lncRNA H19 promotes macrophage activation and hepatic inflammation under cholestatic conditions. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9010190.","journal-title":"Cells"},{"issue":"7","key":"2319_CR54","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41419-021-03931-1","volume":"12","author":"X Tian","year":"2021","unstructured":"Tian X, Wang Y, Lu Y, Wang W, Du J, Chen S, et al. Conditional depletion of macrophages ameliorates cholestatic liver injury and fibrosis via lncRNA-H19. Cell Death Dis. 2021;12(7):646.","journal-title":"Cell Death Dis"},{"key":"2319_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-026-02738-x","author":"M Loria","year":"2026","unstructured":"Loria M, Anello D, Cordaro A, Zichittella C, Fontana S, Alessandro R, et al. Long non-coding RNA H19 transported by colorectal cancer small extracellular vesicles promotes alternative splicing in healthy hepatocytes: new insights on liver pre-metastatic niche formation. Cell Commun Signal. 2026. https:\/\/doi.org\/10.1186\/s12964-026-02738-x.","journal-title":"Cell Commun Signal"},{"key":"2319_CR56","doi-asserted-by":"publisher","DOI":"10.1177\/10732748261448980","volume":"33","author":"J Wang","year":"2026","unstructured":"Wang J, Ye J. The role and mechanisms of tumor-derived exosomes in the formation of the premetastatic niche. Cancer Control. 2026;33:10732748261448980.","journal-title":"Cancer Control"},{"issue":"1","key":"2319_CR57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13046-024-03139-z","volume":"43","author":"A Cordaro","year":"2024","unstructured":"Cordaro A, Barreca MM, Zichittella C, Loria M, Anello D, Arena G, et al. Regulatory role of lncH19 in RAC1 alternative splicing: implication for RAC1B expression in colorectal cancer. J Exp Clin Cancer Res. 2024;43(1):217.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"2319_CR58","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41419-024-06918-w","volume":"15","author":"Z Lei","year":"2024","unstructured":"Lei Z, Zhu Z, Yao Z, Dai X, Dong Y, Chen B, et al. Reciprocal interactions between lncRNAs and MYC in colorectal cancer: partners in crime. Cell Death Dis. 2024;15(7):539.","journal-title":"Cell Death Dis"},{"key":"2319_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0426-x","volume":"14","author":"A Conigliaro","year":"2015","unstructured":"Conigliaro A, Costa V, Lo Dico A, Saieva L, Buccheri S, Dieli F, et al. CD90\u2009+\u2009liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Mol Cancer. 2015;14:155.","journal-title":"Mol Cancer"},{"key":"2319_CR60","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.omtn.2022.05.034","volume":"29","author":"D Wang","year":"2022","unstructured":"Wang D, Zhang W, Zhang C, Wang L, Chen H, Xu J. Exosomal non-coding RNAs have a significant effect on tumor metastasis. Mol Ther Nucleic Acids. 2022;29:16\u201335.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"19","key":"2319_CR61","doi-asserted-by":"publisher","first-page":"7218","DOI":"10.1002\/cam4.3313","volume":"9","author":"D Wang","year":"2020","unstructured":"Wang D, Xing N, Yang T, Liu J, Zhao H, He J, et al. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p\/LIMK1 axis. Cancer Med. 2020;9(19):7218\u201330.","journal-title":"Cancer Med"},{"key":"2319_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101961","volume":"45","author":"RA Assal","year":"2024","unstructured":"Assal RA, Elemam NM, Mekky RY, Attia AA, Soliman AH, Gomaa AI, et al. A novel epigenetic strategy to concurrently block immune checkpoints PD-1\/PD-L1 and CD155\/TIGIT in hepatocellular carcinoma. Transl Oncol. 2024;45:101961.","journal-title":"Transl Oncol"},{"issue":"3","key":"2319_CR63","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1261\/rna.351707","volume":"13","author":"X Cai","year":"2007","unstructured":"Cai X, Cullen BR. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA. 2007;13(3):313\u20136.","journal-title":"RNA"},{"key":"2319_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/biom13010003","author":"S Abdelsattar","year":"2022","unstructured":"Abdelsattar S, Sweed D, Kamel HFM, Kasemy ZA, Gameel AM, Elzohry H, et al. The potential utility of circulating oncofetal H19 derived miR-675 expression versus tissue lncRNA-H19 expression in diagnosis and prognosis of HCC in Egyptian patients. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom13010003.","journal-title":"Biomolecules"},{"issue":"6","key":"2319_CR65","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/liv.15230","volume":"42","author":"\u00c1 Rojas","year":"2022","unstructured":"Rojas \u00c1, Gil-G\u00f3mez A, de la Cruz-Ojeda P, Mu\u00f1oz-Hern\u00e1ndez R, S\u00e1nchez-Torrijos Y, Gallego-Dur\u00e1n R, et al. Long non-coding RNA H19 as a biomarker for hepatocellular carcinoma. Liver Int. 2022;42(6):1410\u201322.","journal-title":"Liver Int"},{"issue":"4","key":"2319_CR66","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","volume":"93","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer. 2005;93(4):387\u201391.","journal-title":"Br J Cancer"},{"issue":"4","key":"2319_CR67","doi-asserted-by":"publisher","first-page":"495","DOI":"10.59249\/TDBJ7410","volume":"96","author":"PR Chowdhury","year":"2023","unstructured":"Chowdhury PR, Salvamani S, Gunasekaran B, Peng HB, Ulaganathan V. H19: An Oncogenic Long Non-coding RNA in Colorectal Cancer. Yale J Biol Med. 2023;96(4):495\u2013509.","journal-title":"Yale J Biol Med"},{"issue":"1","key":"2319_CR68","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s12672-025-04321-1","volume":"17","author":"J Fan","year":"2025","unstructured":"Fan J, Shen D, He L, Yan C, Li H, Zhang Y, et al. The clinical significance of circulating microRNAs as biomarkers in lung cancer diagnosis and prognosis. Discover Oncol. 2025;17(1):126.","journal-title":"Discover Oncol"},{"issue":"6","key":"2319_CR69","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922\u201365.","journal-title":"Hepatology"},{"issue":"20","key":"2319_CR70","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim T-Y, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382(20):1894\u2013905.","journal-title":"N Engl J Med"},{"issue":"8","key":"2319_CR71","doi-asserted-by":"publisher","first-page":"EVIDoa2100070","DOI":"10.1056\/EVIDoa2100070","volume":"1","author":"GK Abou-Alfa","year":"2022","unstructured":"Abou-Alfa GK, Lau G, Kudo M, Chan SL, Kelley RK, Furuse J, et al. Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma. NEJM Evid. 2022;1(8):EVIDoa2100070.","journal-title":"NEJM Evid"},{"issue":"23","key":"2319_CR72","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 T, Shiu K-K, Kim TW, Jensen BV, Jensen LH, Punt C, et al. Pembrolizumab in microsatellite-instability\u2013high advanced colorectal cancer. N Engl J Med. 2020;383(23):2207\u201318.","journal-title":"N Engl J Med"},{"key":"2319_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.814155","volume":"12","author":"R Fasano","year":"2021","unstructured":"Fasano R, Malerba E, Prete M, Solimando AG, Buonavoglia A, Silvestris N, et al. Impact of antigen presentation mechanisms on immune response in autoimmune hepatitis. Front Immunol. 2021;12:814155.","journal-title":"Front Immunol"},{"key":"2319_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.814155","author":"R Fasano","year":"2022","unstructured":"Fasano R, Malerba E, Prete M, Solimando AG, Buonavoglia A, Silvestris N, et al. Impact of antigen presentation mechanisms on immune response in autoimmune hepatitis. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2021.814155.","journal-title":"Front Immunol"},{"issue":"5","key":"2319_CR75","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1053\/jhep.2003.50191","volume":"37","author":"J Herkel","year":"2003","unstructured":"Herkel J, Jagemann B, Wiegard C, Lazaro JF, Lueth S, Kanzler S, et al. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes. Hepatology. 2003;37(5):1079\u201385.","journal-title":"Hepatology"},{"issue":"6","key":"2319_CR76","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.4049\/jimmunol.1502234","volume":"198","author":"JS Dolina","year":"2017","unstructured":"Dolina JS, Cechova S, Rudy CK, Sung S-SJ, Tang WW, Lee J, et al. Cross-Presentation of Soluble and Cell-Associated Antigen by Murine Hepatocytes Is Enhanced by Collectrin Expression. J Immunol. 2017;198(6):2341\u201351.","journal-title":"J Immunol"},{"key":"2319_CR77","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.141462","author":"M Preti","year":"2021","unstructured":"Preti M, Schlott L, L\u00fcbbering D, Krzikalla D, M\u00fcller A-L, Schuran FA, et al. Failure of thymic deletion and instability of autoreactive Tregs drive autoimmunity in immune-privileged liver. JCI Insight. 2021. https:\/\/doi.org\/10.1172\/jci.insight.141462.","journal-title":"JCI Insight"},{"issue":"1","key":"2319_CR78","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1186\/s12935-021-02342-8","volume":"21","author":"Y Lin","year":"2021","unstructured":"Lin Y, Pan X, Chen Z, Lin S, Shen Z, Chen S. Prognostic value and immune infiltration of novel signatures in colon cancer microenvironment. Cancer Cell Int. 2021;21(1):679.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2319_CR79","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12943-025-02477-6","volume":"24","author":"Y-T Liu","year":"2025","unstructured":"Liu Y-T, Wang Y-L, Wang S, Li J-J, He W, Fan X-J, et al. Turning cold tumors into hot tumors to ignite immunotherapy. Mol Cancer. 2025;24(1):254.","journal-title":"Mol Cancer"},{"key":"2319_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101961","volume":"45","author":"RA Assal","year":"2024","unstructured":"Assal RA, Elemam NM, Mekky RY, Attia AA, Soliman AH, Gomaa AI, et al. A novel epigenetic strategy to concurrently block immune checkpoints PD-1\/PD-L1 and CD155\/TIGIT in hepatocellular carcinoma. Transl Oncol. 2024;45:101961.","journal-title":"Transl Oncol"},{"issue":"6","key":"2319_CR81","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s13402-025-01119-9","volume":"48","author":"K Yu","year":"2025","unstructured":"Yu K, Jin Y, Zhou Y, Xu Q. Long non-coding RNA in hepatocellular carcinoma: mechanistic insights and therapeutic perspectives. Cell Oncol (Dordr). 2025;48(6):1677\u201392.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"2319_CR82","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41698-022-00283-7","volume":"6","author":"C Badowski","year":"2022","unstructured":"Badowski C, He B, Garmire LX. Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty. NPJ Precis Oncol. 2022;6(1):40.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"2319_CR83","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12935-025-04105-1","volume":"26","author":"M Bayat","year":"2025","unstructured":"Bayat M, Shahabi P, Rezaei T, Nahand JS. Exosomal regulation of cellular reprogramming and polarization in the tumor microenvironment. Cancer Cell Int. 2025;26(1):11.","journal-title":"Cancer Cell Int"},{"key":"2319_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna9020019","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zeng J, Chen W, Fan J, Hylemon PB, Zhou H. Long noncoding RNA H19: a novel oncogene in liver cancer. Non-coding RNA. 2023. https:\/\/doi.org\/10.3390\/ncrna9020019.","journal-title":"Non-coding RNA"},{"issue":"1","key":"2319_CR85","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13148-015-0053-9","volume":"7","author":"MP Lambert","year":"2015","unstructured":"Lambert MP, Ancey PB, Esposti DD, Cros MP, Sklias A, Scoazec JY, et al. Aberrant DNA methylation of imprinted loci in hepatocellular carcinoma and after in vitro exposure to common risk factors. Clin Epigenetics. 2015;7(1):15.","journal-title":"Clin Epigenetics"},{"issue":"29","key":"2319_CR86","doi-asserted-by":"publisher","first-page":"45370","DOI":"10.18632\/oncotarget.9659","volume":"7","author":"L Zhao","year":"2016","unstructured":"Zhao L, Yu H, Yi S, Peng X, Su P, Xiao Z, et al. The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer. Oncotarget. 2016;7(29):45370\u201384.","journal-title":"Oncotarget"},{"issue":"34","key":"2319_CR87","doi-asserted-by":"publisher","first-page":"12417","DOI":"10.1073\/pnas.0801540105","volume":"105","author":"T Yoshimizu","year":"2008","unstructured":"Yoshimizu T, Miroglio A, Ripoche MA, Gabory A, Vernucci M, Riccio A, et al. The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci U S A. 2008;105(34):12417\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2319_CR88","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.ccell.2023.04.011","volume":"41","author":"J Li","year":"2023","unstructured":"Li J, Wu C, Hu H, Qin G, Wu X, Bai F, et al. Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer. Cancer Cell. 2023;41(6):1152-69.e7.","journal-title":"Cancer Cell"},{"issue":"1","key":"2319_CR89","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-021-01406-7","volume":"20","author":"W Jiang","year":"2021","unstructured":"Jiang W, Pan S, Chen X, Wang ZW, Zhu X. The role of lncRNAs and circRNAs in the PD-1\/PD-L1 pathway in cancer immunotherapy. Mol Cancer. 2021;20(1):116.","journal-title":"Mol Cancer"},{"issue":"1","key":"2319_CR90","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12943-022-01556-2","volume":"21","author":"H Zhou","year":"2022","unstructured":"Zhou H, Zhu L, Song J, Wang G, Li P, Li W, et al. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer. Mol Cancer. 2022;21(1):86.","journal-title":"Mol Cancer"},{"issue":"12","key":"2319_CR91","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41419-018-1187-4","volume":"9","author":"M Wang","year":"2018","unstructured":"Wang M, Han D, Yuan Z, Hu H, Zhao Z, Yang R, et al. Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy. Cell Death Dis. 2018;9(12):1149.","journal-title":"Cell Death Dis"},{"issue":"26","key":"2319_CR92","doi-asserted-by":"publisher","first-page":"22513","DOI":"10.18632\/oncotarget.4154","volume":"6","author":"WC Liang","year":"2015","unstructured":"Liang WC, Fu WM, Wong CW, Wang Y, Wang WM, Hu GX, et al. The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget. 2015;6(26):22513\u201325.","journal-title":"Oncotarget"},{"issue":"12","key":"2319_CR93","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.bulcan.2019.08.011","volume":"106","author":"Y Ye","year":"2019","unstructured":"Ye Y, Shen A, Liu A. Long non-coding RNA H19 and cancer: A competing endogenous RNA. Bull Cancer. 2019;106(12):1152\u20139.","journal-title":"Bull Cancer"},{"issue":"1","key":"2319_CR94","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1186\/s12967-025-06878-5","volume":"23","author":"C Li","year":"2025","unstructured":"Li C, Xing S, Zhang D, Li R, Li Q, Luo H, et al. Exosomal long non-coding RNAs in gastrointestinal cancer: chemoresistance mediators and therapeutic targets. J Translational Med. 2025;23(1):889.","journal-title":"J Translational Med"},{"issue":"1","key":"2319_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03951-3","volume":"25","author":"H Maghsoudi","year":"2025","unstructured":"Maghsoudi H, Rasoulzadeh M, Abbastabar M, Fazilat A, Sheikhnia F, Azizzadeh B, et al. The lncrnas: innovative multifunctional players of drug resistance in colorectal cancer. Cancer Cell Int. 2025;25(1):442.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"2319_CR96","first-page":"423","volume":"41","author":"D Ding","year":"2018","unstructured":"Ding D, Li C, Zhao T, Li D, Yang L, Zhang B. LncRNA H19\/miR-29b-3p\/PGRN Axis Promoted Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Acting on Wnt Signaling. Mol Cells. 2018;41(5):423\u201335.","journal-title":"Mol Cells"},{"issue":"16","key":"2319_CR97","doi-asserted-by":"publisher","first-page":"22159","DOI":"10.18632\/oncotarget.8063","volume":"7","author":"D Han","year":"2016","unstructured":"Han D, Gao X, Wang M, Qiao Y, Xu Y, Yang J, et al. Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3. Oncotarget. 2016;7(16):22159\u201373.","journal-title":"Oncotarget"},{"issue":"1","key":"2319_CR98","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10238-025-01979-3","volume":"26","author":"MS Moeinfar","year":"2025","unstructured":"Moeinfar MS, Morshedi M, Keyhani A, Moosavi SSA, kaikavoosnejad F, Rafiyan M, et al. Regulatory roles of non-coding and exosomal RNAs in colorectal cancer: spotlight on angiogenesis. Clin Experimental Med. 2025;26(1):95.","journal-title":"Clin Experimental Med"},{"key":"2319_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051261","author":"L Tietze","year":"2020","unstructured":"Tietze L, Kessler SM. The good, the bad, the question-H19 in hepatocellular carcinoma. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12051261.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2319_CR100","doi-asserted-by":"publisher","first-page":"37","DOI":"10.15698\/cst2017.10.105","volume":"1","author":"CS Schultheiss","year":"2017","unstructured":"Schultheiss CS, Laggai S, Czepukojc B, Hussein UK, List M, Barghash A, et al. The long non-coding RNA H19 suppresses carcinogenesis and chemoresistance in hepatocellular carcinoma. Cell Stress. 2017;1(1):37\u201354.","journal-title":"Cell Stress"},{"issue":"33","key":"2319_CR101","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1038\/sj.onc.1210266","volume":"26","author":"WP Tsang","year":"2007","unstructured":"Tsang WP, Kwok TT. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells. Oncogene. 2007;26(33):4877\u201381.","journal-title":"Oncogene"},{"issue":"6","key":"2319_CR102","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s13402-025-01119-9","volume":"48","author":"K Yu","year":"2025","unstructured":"Yu K, Jin Y, Zhou Y, Xu Q. Long non-coding RNA in hepatocellular carcinoma: mechanistic insights and therapeutic perspectives. Cell Oncol (Dordr). 2025;48(6):1677\u201392.","journal-title":"Cell Oncol (Dordr)"},{"issue":"3","key":"2319_CR103","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/carcin\/bgs381","volume":"34","author":"L Zhang","year":"2013","unstructured":"Zhang L, Yang F, Yuan J-h, Yuan S-x, Zhou W-p, Huo X-s, et al. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis. 2013;34(3):577\u201386.","journal-title":"Carcinogenesis"},{"key":"2319_CR104","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev","author":"H-C Liu","year":"2022","unstructured":"Liu H-C, Zhu W-Y, Ren L-Y. LncRNA H19 inhibits proliferation and enhances apoptosis of nephroblastoma cells by regulating the miR-675\/TGFBI axis. Eur Rev Med Pharmacol Sci. 2022. https:\/\/doi.org\/10.26355\/eurrev.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"2319_CR105","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0304-3835(97)00264-4","volume":"119","author":"KS Kim","year":"1997","unstructured":"Kim KS, Lee YI. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Cancer Lett. 1997;119(2):143\u20138.","journal-title":"Cancer Lett"},{"issue":"2","key":"2319_CR106","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.bbrc.2010.12.052","volume":"404","author":"JY Song","year":"2011","unstructured":"Song JY, Lee JH, Joe CO, Lim DS, Chung JH. Retrotransposon-specific DNA hypomethylation and two-step loss-of-imprinting during WW45 haploinsufficiency-induced hepatocarcinogenesis. Biochem Biophys Res Commun. 2011;404(2):728\u201334.","journal-title":"Biochem Biophys Res Commun"},{"key":"2319_CR107","doi-asserted-by":"publisher","first-page":"1005522","DOI":"10.3389\/fgene.2022.1005522","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang X, Luo M, Zhang J, Guo B, Singh S, Lin X, et al. The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers. Front Genet. 2022;13:1005522.","journal-title":"Front Genet"},{"key":"2319_CR108","doi-asserted-by":"crossref","unstructured":"Zichittella C, Loria M, Celesia A, Di Liberto D, Corrado C, Alessandro R et al. Long non-coding RNA H19 enhances the pro-apoptotic activity of ITF2357 (a histone deacetylase inhibitor) in colorectal cancer cells. Front Pharmacol. 2023;Volume 14\u20132023.","DOI":"10.3389\/fphar.2023.1275833"},{"issue":"8","key":"2319_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23311","volume":"34","author":"B Yu","year":"2020","unstructured":"Yu B, Chen J, Hou C, Zhang L, Jia J. LncRNA H19 gene rs2839698 polymorphism is associated with a decreased risk of colorectal cancer in a Chinese Han population: a case-control study. J Clin Lab Anal. 2020;34(8):e23311.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"2319_CR110","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1186\/s12885-023-11164-y","volume":"23","author":"M Yang","year":"2023","unstructured":"Yang M, Zhang M, Wang Q, Guo X, Geng P, Gu J, et al. Six polymorphisms in the lncRNA H19 gene and the risk of cancer: a systematic review and meta-analysis. BMC Cancer. 2023;23(1):688.","journal-title":"BMC Cancer"},{"issue":"9","key":"2319_CR111","doi-asserted-by":"publisher","first-page":"e845","DOI":"10.1371\/journal.pone.0000845","volume":"2","author":"IJ Matouk","year":"2007","unstructured":"Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, et al. The H19 non-coding RNA is essential for human tumor growth. PLoS ONE. 2007;2(9):e845.","journal-title":"PLoS ONE"},{"issue":"1","key":"2319_CR112","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13046-020-01619-6","volume":"39","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Huang W, Yuan Y, Li J, Wu J, Yu J, et al. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1. J Exp Clin Cancer Res. 2020;39(1):141.","journal-title":"J Exp Clin Cancer Res"},{"key":"2319_CR113","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ebiom.2016.10.026","volume":"13","author":"M Ohtsuka","year":"2016","unstructured":"Ohtsuka M, Ling H, Ivan C, Pichler M, Matsushita D, Goblirsch M, et al. H19 noncoding RNA, an independent prognostic factor, regulates essential Rb-E2F and CDK8-\u03b2-catenin signaling in colorectal cancer. EBioMedicine. 2016;13:113\u201324.","journal-title":"EBioMedicine"},{"issue":"8","key":"2319_CR114","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1158\/0008-5472.CAN-16-3236","volume":"77","author":"M Rokavec","year":"2017","unstructured":"Rokavec M, Horst D, Hermeking H. Cellular Model of Colon Cancer Progression Reveals Signatures of mRNAs, miRNA, lncRNAs, and Epigenetic Modifications Associated with Metastasis. Cancer Res. 2017;77(8):1854\u201367.","journal-title":"Cancer Res"},{"key":"2319_CR115","doi-asserted-by":"publisher","DOI":"10.37349\/edd.2026.1005120","volume":"5","author":"M Sulaiman","year":"2026","unstructured":"Sulaiman M, Nie Y, Chen Z, Hani UE, Raza F, Yahya MM, et al. LncRNAs in hepatocellular carcinoma: molecular drivers and emerging therapeutic targets. Explor Dig Dis. 2026;5:1005120.","journal-title":"Explor Dig Dis"},{"key":"2319_CR116","first-page":"101695","volume":"38","author":"M Shi","year":"2024","unstructured":"Shi M, Jia JS, Gao GS, Hua X. Advances and challenges of exosome-derived noncoding RNAs for hepatocellular carcinoma diagnosis and treatment. Biochem Biophys Rep. 2024;38:101695.","journal-title":"Biochem Biophys Rep"},{"key":"2319_CR117","doi-asserted-by":"publisher","first-page":"105234","DOI":"10.1016\/j.critrevonc.2026.105234","volume":"222","author":"M Chen","year":"2026","unstructured":"Chen M, Wang W, Jie D, Gu L. Interplay between exosomes and the PD-1\/PD-L1 axis in hepatocellular carcinoma: Implications for immune escape and immunotherapy. Crit Rev Oncol\/Hematol. 2026;222:105234.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"2","key":"2319_CR118","doi-asserted-by":"publisher","first-page":"e23165","DOI":"10.1096\/fj.202300203R","volume":"38","author":"S Tao","year":"2024","unstructured":"Tao S, Wang J, Li F, Shi B, Ren Q, Zhuang Y, et al. Extracellular vesicles released by hypoxia-induced tumor-associated fibroblasts impart chemoresistance to breast cancer cells via long noncoding RNA H19 delivery. Faseb j. 2024;38(2):e23165.","journal-title":"Faseb j"},{"key":"2319_CR119","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.2147\/CMAR.S241095","volume":"12","author":"R Pan","year":"2020","unstructured":"Pan R, Zhou H. Exosomal transfer of lncRNA H19 promotes erlotinib resistance in non-small cell lung cancer via miR-615-3p\/ATG7 axis. Cancer Manag Res. 2020;12:4283\u201397.","journal-title":"Cancer Manag Res"},{"key":"2319_CR120","doi-asserted-by":"publisher","first-page":"9307","DOI":"10.12659\/MSM.912018","volume":"24","author":"J Wang","year":"2018","unstructured":"Wang J, Yang K, Yuan W, Gao Z. Determination of serum exosomal H19 as a noninvasive biomarker for bladder cancer diagnosis and prognosis. Med Sci Monit. 2018;24:9307\u201316.","journal-title":"Med Sci Monit"},{"issue":"11","key":"2319_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101806","volume":"5","author":"J Chen","year":"2024","unstructured":"Chen J, Gao Y, Zhong J, Wu X, Leng Z, Liu M, et al. Lnc-H19-derived protein shapes the immunosuppressive microenvironment of glioblastoma. Cell Rep Med. 2024;5(11):101806.","journal-title":"Cell Rep Med"},{"issue":"1","key":"2319_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11743-z","volume":"24","author":"M Ghasemian","year":"2024","unstructured":"Ghasemian M, Zehtabi M, Dari MAG, Pour FK, Tabesh GA, Moramezi F, et al. The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers. BMC Cancer. 2024;24(1):4.","journal-title":"BMC Cancer"},{"issue":"1","key":"2319_CR123","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12943-025-02549-7","volume":"25","author":"G Chen","year":"2026","unstructured":"Chen G, Liang Y, Yan Y, Zou J, Zhang J, Zeng X, et al. Non-coding RNAs: modulators of signaling pathways and prognostic biomarkers in digestive system cancer. Mol Cancer. 2026;25(1):128.","journal-title":"Mol Cancer"},{"issue":"1","key":"2319_CR124","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12943-025-02536-y","volume":"25","author":"M Chang","year":"2026","unstructured":"Chang M, Papazyan T, Pons-Tostivint E, Fradin D. Unlocking the power of non-coding RNAs: toward real-time cancer monitoring in precision oncology. Mol Cancer. 2026;25(1):34.","journal-title":"Mol Cancer"},{"issue":"9","key":"2319_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.21933","volume":"31","author":"Z Li","year":"2017","unstructured":"Li Z, Li Y, Li Y, Ren K, Li X, Han X, et al. Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152. J Biochem Mol Toxicol. 2017;31(9):e21933.","journal-title":"J Biochem Mol Toxicol"},{"issue":"3","key":"2319_CR126","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cellsig.2014.12.003","volume":"27","author":"X Wang","year":"2015","unstructured":"Wang X, Li J, Dong K, Lin F, Long M, Ouyang Y, et al. Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia. Cell Signal. 2015;27(3):443\u201352.","journal-title":"Cell Signal"},{"issue":"3","key":"2319_CR127","first-page":"929","volume":"54","author":"L Liu","year":"2019","unstructured":"Liu L, Liu L, Lu S. lncRNA H19 promotes viability and epithelial-mesenchymal transition of lung adenocarcinoma cells by targeting miR-29b-3p and modifying STAT3. Int J Oncol. 2019;54(3):929\u201341.","journal-title":"Int J Oncol"},{"issue":"24","key":"2319_CR128","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1038\/onc.2014.254","volume":"34","author":"HI Suzuki","year":"2015","unstructured":"Suzuki HI, Katsura A, Matsuyama H, Miyazono K. MicroRNA regulons in tumor microenvironment. Oncogene. 2015;34(24):3085\u201394.","journal-title":"Oncogene"},{"issue":"1","key":"2319_CR129","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41388-020-01513-7","volume":"40","author":"L Gamaev","year":"2021","unstructured":"Gamaev L, Mizrahi L, Friehmann T, Rosenberg N, Pappo O, Olam D, et al. The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma. Oncogene. 2021;40(1):127\u201339.","journal-title":"Oncogene"},{"issue":"9","key":"2319_CR130","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/biology10090918","volume":"10","author":"CT Ng","year":"2021","unstructured":"Ng CT, Azwar S, Yip WK, Zahari Sham SY, Faisal Jabar M, Sahak NH, et al. Isolation and identification of long non-coding RNAs in exosomes derived from the serum of colorectal carcinoma patients. Biology. 2021;10(9):918.","journal-title":"Biology"},{"issue":"3","key":"2319_CR131","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.molcel.2016.09.027","volume":"64","author":"R Denzler","year":"2016","unstructured":"Denzler R, McGeary SE, Agarwal V, Bartel DP, Stoffel M. Impact of microRNA levels, target-site complementarity, and cooperativity on competing endogenous RNA-regulated gene expression. Mol Cell. 2016;64(3):565\u201379.","journal-title":"Mol Cell"},{"issue":"2","key":"2319_CR132","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12854","volume":"22","author":"A Samir","year":"2021","unstructured":"Samir A, Tawab RA, El Tayebi HM. Long non-coding RNAs XIST and MALAT1 hijack the PD-L1 regulatory signaling pathway in breast cancer subtypes. Oncol Lett. 2021;22(2):593.","journal-title":"Oncol Lett"},{"key":"2319_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0458-2","volume":"14","author":"E Raveh","year":"2015","unstructured":"Raveh E, Matouk IJ, Gilon M, Hochberg A. The H19 long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory. Mol Cancer. 2015;14:184.","journal-title":"Mol Cancer"},{"key":"2319_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109774","volume":"123","author":"S Ghafouri-Fard","year":"2020","unstructured":"Ghafouri-Fard S, Esmaeili M, Taheri M. H19 lncRNA: roles in tumorigenesis. Biomed Pharmacother. 2020;123:109774.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"2319_CR135","first-page":"607","volume":"12","author":"MC Smaldone","year":"2010","unstructured":"Smaldone MC, Davies BJ. BC-819, a plasmid comprising the H19 gene regulatory sequences and diphtheria toxin A, for the potential targeted therapy of cancers. Curr Opin Mol Ther. 2010;12(5):607\u201316.","journal-title":"Curr Opin Mol Ther"},{"issue":"6","key":"2319_CR136","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.juro.2008.08.006","volume":"180","author":"AA Sidi","year":"2008","unstructured":"Sidi AA, Ohana P, Benjamin S, Shalev M, Ransom JH, Lamm D, et al. Phase I\/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. J Urol. 2008;180(6):2379\u201383.","journal-title":"J Urol"},{"key":"2319_CR137","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1479-5876-8-134","volume":"8","author":"D Amit","year":"2010","unstructured":"Amit D, Hochberg A. Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences. J Transl Med. 2010;8:134.","journal-title":"J Transl Med"},{"key":"2319_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9040433","author":"M Gagliardi","year":"2021","unstructured":"Gagliardi M, Ashizawa AT. The challenges and strategies of antisense oligonucleotide drug delivery. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9040433.","journal-title":"Biomedicines"},{"issue":"23","key":"2319_CR139","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1039\/D4NA00501E","volume":"6","author":"SS Palakurthi","year":"2024","unstructured":"Palakurthi SS, Shah B, Kapre S, Charbe N, Immanuel S, Pasham S, et al. A comprehensive review of challenges and advances in exosome-based drug delivery systems. Nanoscale Adv. 2024;6(23):5803\u201326.","journal-title":"Nanoscale Adv"},{"key":"2319_CR140","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2147\/IJN.S388916","volume":"18","author":"J Zhang","year":"2023","unstructured":"Zhang J, Song H, Dong Y, Li G, Li J, Cai Q, et al. Surface Engineering of HEK293 Cell-Derived Extracellular Vesicles for Improved Pharmacokinetic Profile and Targeted Delivery of IL-12 for the Treatment of Hepatocellular Carcinoma. Int J Nanomed. 2023;18:209\u201323.","journal-title":"Int J Nanomed"},{"issue":"10","key":"2319_CR141","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3390\/cancers18101619","volume":"18","author":"M Parvin","year":"2026","unstructured":"Parvin M, Alptekin A, Kashif S, Selina FA, Bushra MA, Syam M, et al. Therapeutically Engineering Exosomes to Target CD206\u2009+\u2009M2 Macrophages to Prevent the Development of Primary Tumors and Distal Metastases in Breast Cancers. Cancers. 2026;18(10):1619.","journal-title":"Cancers"},{"issue":"2","key":"2319_CR142","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1074\/mcp.M900152-MCP200","volume":"9","author":"S Mathivanan","year":"2010","unstructured":"Mathivanan S, Lim JW, Tauro BJ, Ji H, Moritz RL, Simpson RJ. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol Cell Proteom. 2010;9(2):197\u2013208.","journal-title":"Mol Cell Proteom"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02319-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02319-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02319-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:02:30Z","timestamp":1791316950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02319-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,6]]},"references-count":142,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2319"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02319-9","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,6]]},"assertion":[{"value":"22 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not involve human participants, human data, or animals.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study does not include any individual person\u2019s data in any form.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Ethical Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ChatGPT and Grammarly were used to paraphrase and summarize sentences.","order":5,"name":"Ethics","label":"AI declaration","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"347"}}